# ALA on Glycemic Control in T2DM Participants

> **NCT02701894** · — · UNKNOWN · sponsor: **Unity Health Toronto** · enrollment: 200 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** Alpha-Linolenic Acid

## Key facts

- **NCT ID:** NCT02701894
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2016-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02701894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02701894, "ALA on Glycemic Control in T2DM Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02701894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*